Request for Covid-19 Impact Assessment of this Report
The United States Rotavirus Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rotavirus Vaccines market, reaching US$ million by the year 2028. As for the Europe Rotavirus Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Rotavirus Vaccines players cover Bharat Biotech, Merck & Co., Inc, GlaxoSmithKline plc, and Lanzhou Institute of Biological, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rotavirus Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Adult
Pediatric
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bharat Biotech
Merck & Co., Inc
GlaxoSmithKline plc
Lanzhou Institute of Biological
Bharat Biotech International Limited
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rotavirus Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Rotavirus Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Rotavirus Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Rotavirus Vaccines Segment by Type
2.2.1 Rotarix
2.2.2 RotaTeq
2.2.3 Rotavac
2.2.4 Rotavin-M1
2.2.5 Lanzhou lamb
2.2.6 Others
2.3 Rotavirus Vaccines Sales by Type
2.3.1 Global Rotavirus Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Rotavirus Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Rotavirus Vaccines Sale Price by Type (2017-2022)
2.4 Rotavirus Vaccines Segment by Application
2.4.1 Adult
2.4.2 Pediatric
2.5 Rotavirus Vaccines Sales by Application
2.5.1 Global Rotavirus Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Rotavirus Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Rotavirus Vaccines Sale Price by Application (2017-2022)
3 Global Rotavirus Vaccines by Company
3.1 Global Rotavirus Vaccines Breakdown Data by Company
3.1.1 Global Rotavirus Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Rotavirus Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Rotavirus Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Rotavirus Vaccines Revenue by Company (2020-2022)
3.2.2 Global Rotavirus Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Rotavirus Vaccines Sale Price by Company
3.4 Key Manufacturers Rotavirus Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rotavirus Vaccines Product Location Distribution
3.4.2 Players Rotavirus Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rotavirus Vaccines by Geographic Region
4.1 World Historic Rotavirus Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Rotavirus Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Rotavirus Vaccines Annual Revenue by Geographic Region
4.2 World Historic Rotavirus Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Rotavirus Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Rotavirus Vaccines Annual Revenue by Country/Region
4.3 Americas Rotavirus Vaccines Sales Growth
4.4 APAC Rotavirus Vaccines Sales Growth
4.5 Europe Rotavirus Vaccines Sales Growth
4.6 Middle East & Africa Rotavirus Vaccines Sales Growth
5 Americas
5.1 Americas Rotavirus Vaccines Sales by Country
5.1.1 Americas Rotavirus Vaccines Sales by Country (2017-2022)
5.1.2 Americas Rotavirus Vaccines Revenue by Country (2017-2022)
5.2 Americas Rotavirus Vaccines Sales by Type
5.3 Americas Rotavirus Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rotavirus Vaccines Sales by Region
6.1.1 APAC Rotavirus Vaccines Sales by Region (2017-2022)
6.1.2 APAC Rotavirus Vaccines Revenue by Region (2017-2022)
6.2 APAC Rotavirus Vaccines Sales by Type
6.3 APAC Rotavirus Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rotavirus Vaccines by Country
7.1.1 Europe Rotavirus Vaccines Sales by Country (2017-2022)
7.1.2 Europe Rotavirus Vaccines Revenue by Country (2017-2022)
7.2 Europe Rotavirus Vaccines Sales by Type
7.3 Europe Rotavirus Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rotavirus Vaccines by Country
8.1.1 Middle East & Africa Rotavirus Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Rotavirus Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Rotavirus Vaccines Sales by Type
8.3 Middle East & Africa Rotavirus Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rotavirus Vaccines
10.3 Manufacturing Process Analysis of Rotavirus Vaccines
10.4 Industry Chain Structure of Rotavirus Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rotavirus Vaccines Distributors
11.3 Rotavirus Vaccines Customer
12 World Forecast Review for Rotavirus Vaccines by Geographic Region
12.1 Global Rotavirus Vaccines Market Size Forecast by Region
12.1.1 Global Rotavirus Vaccines Forecast by Region (2023-2028)
12.1.2 Global Rotavirus Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rotavirus Vaccines Forecast by Type
12.7 Global Rotavirus Vaccines Forecast by Application
13 Key Players Analysis
13.1 Bharat Biotech
13.1.1 Bharat Biotech Company Information
13.1.2 Bharat Biotech Rotavirus Vaccines Product Offered
13.1.3 Bharat Biotech Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bharat Biotech Main Business Overview
13.1.5 Bharat Biotech Latest Developments
13.2 Merck & Co., Inc
13.2.1 Merck & Co., Inc Company Information
13.2.2 Merck & Co., Inc Rotavirus Vaccines Product Offered
13.2.3 Merck & Co., Inc Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck & Co., Inc Main Business Overview
13.2.5 Merck & Co., Inc Latest Developments
13.3 GlaxoSmithKline plc
13.3.1 GlaxoSmithKline plc Company Information
13.3.2 GlaxoSmithKline plc Rotavirus Vaccines Product Offered
13.3.3 GlaxoSmithKline plc Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 GlaxoSmithKline plc Main Business Overview
13.3.5 GlaxoSmithKline plc Latest Developments
13.4 Lanzhou Institute of Biological
13.4.1 Lanzhou Institute of Biological Company Information
13.4.2 Lanzhou Institute of Biological Rotavirus Vaccines Product Offered
13.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lanzhou Institute of Biological Main Business Overview
13.4.5 Lanzhou Institute of Biological Latest Developments
13.5 Bharat Biotech International Limited
13.5.1 Bharat Biotech International Limited Company Information
13.5.2 Bharat Biotech International Limited Rotavirus Vaccines Product Offered
13.5.3 Bharat Biotech International Limited Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bharat Biotech International Limited Main Business Overview
13.5.5 Bharat Biotech International Limited Latest Developments
14 Research Findings and Conclusion
Table 1. Rotavirus Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Rotavirus Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Rotarix
Table 4. Major Players of RotaTeq
Table 5. Major Players of Rotavac
Table 6. Major Players of Rotavin-M1
Table 7. Major Players of Lanzhou lamb
Table 8. Major Players of Others
Table 9. Global Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
Table 10. Global Rotavirus Vaccines Sales Market Share by Type (2017-2022)
Table 11. Global Rotavirus Vaccines Revenue by Type (2017-2022) & ($ million)
Table 12. Global Rotavirus Vaccines Revenue Market Share by Type (2017-2022)
Table 13. Global Rotavirus Vaccines Sale Price by Type (2017-2022) & (USD/Unit)
Table 14. Global Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
Table 15. Global Rotavirus Vaccines Sales Market Share by Application (2017-2022)
Table 16. Global Rotavirus Vaccines Revenue by Application (2017-2022)
Table 17. Global Rotavirus Vaccines Revenue Market Share by Application (2017-2022)
Table 18. Global Rotavirus Vaccines Sale Price by Application (2017-2022) & (USD/Unit)
Table 19. Global Rotavirus Vaccines Sales by Company (2020-2022) & (K Units)
Table 20. Global Rotavirus Vaccines Sales Market Share by Company (2020-2022)
Table 21. Global Rotavirus Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Rotavirus Vaccines Revenue Market Share by Company (2020-2022)
Table 23. Global Rotavirus Vaccines Sale Price by Company (2020-2022) & (USD/Unit)
Table 24. Key Manufacturers Rotavirus Vaccines Producing Area Distribution and Sales Area
Table 25. Players Rotavirus Vaccines Products Offered
Table 26. Rotavirus Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Rotavirus Vaccines Sales by Geographic Region (2017-2022) & (K Units)
Table 30. Global Rotavirus Vaccines Sales Market Share Geographic Region (2017-2022)
Table 31. Global Rotavirus Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Rotavirus Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Rotavirus Vaccines Sales by Country/Region (2017-2022) & (K Units)
Table 34. Global Rotavirus Vaccines Sales Market Share by Country/Region (2017-2022)
Table 35. Global Rotavirus Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Rotavirus Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Rotavirus Vaccines Sales by Country (2017-2022) & (K Units)
Table 38. Americas Rotavirus Vaccines Sales Market Share by Country (2017-2022)
Table 39. Americas Rotavirus Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Rotavirus Vaccines Revenue Market Share by Country (2017-2022)
Table 41. Americas Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
Table 42. Americas Rotavirus Vaccines Sales Market Share by Type (2017-2022)
Table 43. Americas Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
Table 44. Americas Rotavirus Vaccines Sales Market Share by Application (2017-2022)
Table 45. APAC Rotavirus Vaccines Sales by Region (2017-2022) & (K Units)
Table 46. APAC Rotavirus Vaccines Sales Market Share by Region (2017-2022)
Table 47. APAC Rotavirus Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Rotavirus Vaccines Revenue Market Share by Region (2017-2022)
Table 49. APAC Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
Table 50. APAC Rotavirus Vaccines Sales Market Share by Type (2017-2022)
Table 51. APAC Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
Table 52. APAC Rotavirus Vaccines Sales Market Share by Application (2017-2022)
Table 53. Europe Rotavirus Vaccines Sales by Country (2017-2022) & (K Units)
Table 54. Europe Rotavirus Vaccines Sales Market Share by Country (2017-2022)
Table 55. Europe Rotavirus Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Rotavirus Vaccines Revenue Market Share by Country (2017-2022)
Table 57. Europe Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
Table 58. Europe Rotavirus Vaccines Sales Market Share by Type (2017-2022)
Table 59. Europe Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
Table 60. Europe Rotavirus Vaccines Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Rotavirus Vaccines Sales by Country (2017-2022) & (K Units)
Table 62. Middle East & Africa Rotavirus Vaccines Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Rotavirus Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Rotavirus Vaccines Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Rotavirus Vaccines Sales by Type (2017-2022) & (K Units)
Table 66. Middle East & Africa Rotavirus Vaccines Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Rotavirus Vaccines Sales by Application (2017-2022) & (K Units)
Table 68. Middle East & Africa Rotavirus Vaccines Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Rotavirus Vaccines
Table 70. Key Market Challenges & Risks of Rotavirus Vaccines
Table 71. Key Industry Trends of Rotavirus Vaccines
Table 72. Rotavirus Vaccines Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Rotavirus Vaccines Distributors List
Table 75. Rotavirus Vaccines Customer List
Table 76. Global Rotavirus Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 77. Global Rotavirus Vaccines Sales Market Forecast by Region
Table 78. Global Rotavirus Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Rotavirus Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Rotavirus Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Americas Rotavirus Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Rotavirus Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 83. APAC Rotavirus Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Rotavirus Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Europe Rotavirus Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Rotavirus Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 87. Middle East & Africa Rotavirus Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Rotavirus Vaccines Sales Forecast by Type (2023-2028) & (K Units)
Table 89. Global Rotavirus Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Rotavirus Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Rotavirus Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Rotavirus Vaccines Sales Forecast by Application (2023-2028) & (K Units)
Table 93. Global Rotavirus Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Rotavirus Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Rotavirus Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 96. Bharat Biotech Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 97. Bharat Biotech Rotavirus Vaccines Product Offered
Table 98. Bharat Biotech Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 99. Bharat Biotech Main Business
Table 100. Bharat Biotech Latest Developments
Table 101. Merck & Co., Inc Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 102. Merck & Co., Inc Rotavirus Vaccines Product Offered
Table 103. Merck & Co., Inc Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 104. Merck & Co., Inc Main Business
Table 105. Merck & Co., Inc Latest Developments
Table 106. GlaxoSmithKline plc Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 107. GlaxoSmithKline plc Rotavirus Vaccines Product Offered
Table 108. GlaxoSmithKline plc Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 109. GlaxoSmithKline plc Main Business
Table 110. GlaxoSmithKline plc Latest Developments
Table 111. Lanzhou Institute of Biological Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 112. Lanzhou Institute of Biological Rotavirus Vaccines Product Offered
Table 113. Lanzhou Institute of Biological Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 114. Lanzhou Institute of Biological Main Business
Table 115. Lanzhou Institute of Biological Latest Developments
Table 116. Bharat Biotech International Limited Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 117. Bharat Biotech International Limited Rotavirus Vaccines Product Offered
Table 118. Bharat Biotech International Limited Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 119. Bharat Biotech International Limited Main Business
Table 120. Bharat Biotech International Limited Latest Developments
List of Figures
Figure 1. Picture of Rotavirus Vaccines
Figure 2. Rotavirus Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rotavirus Vaccines Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Rotavirus Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Rotavirus Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Rotarix
Figure 10. Product Picture of RotaTeq
Figure 11. Product Picture of Rotavac
Figure 12. Product Picture of Rotavin-M1
Figure 13. Product Picture of Lanzhou lamb
Figure 14. Product Picture of Others
Figure 15. Global Rotavirus Vaccines Sales Market Share by Type in 2021
Figure 16. Global Rotavirus Vaccines Revenue Market Share by Type (2017-2022)
Figure 17. Rotavirus Vaccines Consumed in Adult
Figure 18. Global Rotavirus Vaccines Market: Adult (2017-2022) & (K Units)
Figure 19. Rotavirus Vaccines Consumed in Pediatric
Figure 20. Global Rotavirus Vaccines Market: Pediatric (2017-2022) & (K Units)
Figure 21. Global Rotavirus Vaccines Sales Market Share by Application (2017-2022)
Figure 22. Global Rotavirus Vaccines Revenue Market Share by Application in 2021
Figure 23. Rotavirus Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Rotavirus Vaccines Revenue Market Share by Company in 2021
Figure 25. Global Rotavirus Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Rotavirus Vaccines Revenue Market Share by Geographic Region in 2021
Figure 27. Global Rotavirus Vaccines Sales Market Share by Region (2017-2022)
Figure 28. Global Rotavirus Vaccines Revenue Market Share by Country/Region in 2021
Figure 29. Americas Rotavirus Vaccines Sales 2017-2022 (K Units)
Figure 30. Americas Rotavirus Vaccines Revenue 2017-2022 ($ Millions)
Figure 31. APAC Rotavirus Vaccines Sales 2017-2022 (K Units)
Figure 32. APAC Rotavirus Vaccines Revenue 2017-2022 ($ Millions)
Figure 33. Europe Rotavirus Vaccines Sales 2017-2022 (K Units)
Figure 34. Europe Rotavirus Vaccines Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Rotavirus Vaccines Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Rotavirus Vaccines Revenue 2017-2022 ($ Millions)
Figure 37. Americas Rotavirus Vaccines Sales Market Share by Country in 2021
Figure 38. Americas Rotavirus Vaccines Revenue Market Share by Country in 2021
Figure 39. United States Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Rotavirus Vaccines Sales Market Share by Region in 2021
Figure 44. APAC Rotavirus Vaccines Revenue Market Share by Regions in 2021
Figure 45. China Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Rotavirus Vaccines Sales Market Share by Country in 2021
Figure 52. Europe Rotavirus Vaccines Revenue Market Share by Country in 2021
Figure 53. Germany Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Rotavirus Vaccines Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Rotavirus Vaccines Revenue Market Share by Country in 2021
Figure 60. Egypt Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Rotavirus Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Rotavirus Vaccines in 2021
Figure 66. Manufacturing Process Analysis of Rotavirus Vaccines
Figure 67. Industry Chain Structure of Rotavirus Vaccines
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...